Skip to main content
. 2016 Nov 11;8(14):23862–23870. doi: 10.18632/oncotarget.13317

Figure 2. Kaplan-Meier estimated PFS and OS stratified by residual mass.

Figure 2

A. Progression free survival calculated by log-rank test. (without residual mass vs with residual mass, P < 0.01) and B. Overall survival calculated by log-rank test. (without residual mass vs with residual mass, P < 0.01).